90 results about "Body organs" patented technology

A urinary dysfunction treatment apparatus is provided. The apparatus comprises an implantable constriction device configured to constrict at least one portion of the tissue wall of a patient's urethra to at least restrict the flow of urine, an operation device for operating the constriction device to change the constriction of the urethra, a control unit for controlling the operation device, wherein the control unit is configured to: control the operation device to constrict the urethra, and control the operation device to release the urethra, and a source of energy for supplying energy to the operation device. The control unit is configured to determine a current state of the source of energy, and wherein the control unit is connected to an internal signal transmitter configured to transmit information related to the current state of the source of energy.

The invention provides an application of a compound Aldometanib in preparation of a medicine for preventing and treating immune-related adverse reactions and diseases. Based on the first discovered prevention and treatment effects of Aldometanib on fatal immune hepatitis, immune myocarditis, pneumonia and enteritis, the invention specifically discloses application of Aldometanib in preparation of drugs for prevention and treatment of immune-related adverse reactions and diseases, and the main mechanism is that Aldometanib activates immune cells AMPK, enhances catabolism of immune cells, promotes immune cell apoptosis, promotes immune cell apoptosis, and improves immune cell apoptosis. The anabolism of the immune cells is inhibited, so that the expression of effector factors of the immune cells is controlled, and inflammatory factor storm is inhibited. Aldometanib has the effects of preventing the occurrence of immune-related adverse reactions and diseases, and inhibiting the attack levels of the immune-related adverse reactions and diseases, so that non-lethal and lethal injuries caused by an immune system to body organs are reduced.

The present disclosure relates to a method for three-dimensionally modeling an organ through image segmentation. The three-dimensional modeling of an organ includes the operations of: receiving one or more pieces of medical image data for a specific bodily organ of a target object; setting a region of interest with respect to the bodily organ based on the one or more pieces of medical image data; forming one or more blocks corresponding to the region of interest, wherein the blocks include a portion of the bodily organ corresponding to the regions of interest; setting a segment algorithm for each of the blocks; generating first image data respectively performing 3D modeling of portions contained in the blocks based on algorithms set to the blocks; and merging the first image data, and generating a three-dimensional section image data with respect to the entire bodily organ.

The invention relates to internet-of-things digital intelligent medicine and medicine interaction virtual-real fusion terminal equipment, and aims to solve the problem of medicine selection deviation caused by insufficient medical knowledge of a user in a traditional medicine purchasing process. The device obtains user symptoms through multi-mode interaction (voice, touch screen and video), generates a combined medication scheme based on a cloud medical knowledge base and a medicine database, and introduces a doctor, pharmacist and licensed pharmacist auditing mechanism to guarantee scientific medication and safe medication of the user. The system supports four payment modes and two medicine taking modes (self-pick-up / delivery), realizes full-process intelligentization from symptom analysis to medicine delivery, and adapts to full-process digitalization from body organ part-part symptom to medicine delivery in local dialects. According to the method, the user can be guided to accurately purchase medicines with scientific and safe medication according to the disease symptoms, the correspondence between the medicines purchased by the user and the disease symptoms is improved, the risk of wrong medication of the user is reduced, and the accuracy of scientific and professional medication is improved.

The present invention provides an improved vascular occlusion device having improved flexibility and retention of the type fabricated from braided tubular metal fabric having an expanded preset configuration and an elongated collapsed reduced diameter configuration for delivery through a catheter to a treatment site and shaped to create an occlusion of an abnormal opening in a body organ or vessel, the woven metal fabric having a memory property whereby the medical device tends to return to said expanded preset configuration when unconstrained. The device further including at least one disk portion adjacent a body cylindrical portion formed from the fabric and having a transition diameter between the disk and cylindrical portion, significantly smaller than the diameter of the disk and the diameter of the cylindrical portion.

A method and system for assisting a physician compute the 3D location of the tip of a surgical device inserted into a patient is described. A trained model computes the 3D location of the hidden portion of the surgical device based on live image data of the operative field. A display shows the tip of the surgical device and a 3D model of the body organ in a fused arrangement.

The present invention relates to a light therapy apparatus, system, and method to deliver light to a body organ, e.g., to directly contact the skin such as a scalp, via one or more light guides in therapeutic dosages from one or more light sources operating in a variety of wavelengths. One or more illumination assemblies may be fixedly coupled to two or more panel assemblies operably coupled to a substructure. The panel assemblies may be acted upon by one or more actuators to move the panel assemblies resulting in conformal contact with the body organ from a first position to a second position. The actuator may comprise a cable coupled to a motor, the cable operably coupled to each panel assembly, so that upon activation of the motor, the panel assemblies each move inwardly in an independent direction with respect to each other to conform to the body organ.

The present invention describes a system and method for estimating physiological signs in dark environment with luminance threshold of 1 lux or less. This invention, which is technically related to the biomedical engineering area, enables contactless sleep monitoring, in home-based monitoring for example, where physiological signs could be used for health monitoring, or to identify the diseased state of the subject. The proposed invention can also be applied in various healthcare facilities, general wards, ICUs (intensive care unit), NICUs (Neonatal Intensive Care Unit), etc. for physiological signs estimations or contactless sleep monitoring. Furthermore, this invention also encourages and enables home-based health monitoring through a InSite implementation, particularly in a subject's sleeping bedroom. Furthermore, it can be used in scenarios that avoid physical contact with the subject's body organs, such as burnt or sensitive skin, neonatal physiological signs estimations, contactless sleep monitoring, and driving scenarios during extremely dark conditions.

The method includes receiving or generating (i) a volumetric map of at least a portion of a cavity of a body organ including a plurality of mapping locations, and (ii) ablation locations within the cavity. The volumetric map is updated by removing a portion of the mapping locations such that the ablation locations within the cavity fall on a surface of the volumetric map. Using the updated volumetric map, a map of at least a portion of the cavity is generated including the ablation locations located on a surface of the updated volumetric map. The map is displayed to a user.

An apparatus for use in tissue removal from a body organ is presented. The apparatus comprises a hand-held probe device, a rotating motor device and a connection assembly configured for removably interconnecting between the hand-held probe device and the rotating motor device. The hand-held probe device is disposable and comprises a housing having proximal and distal ends, a rotatable cutting tool extending distally from the distal end of the housing and being configured for cutting and removing tissue during rotation, and a transmission assembly passing inside the housing between the proximal and distal ends and being configured for transmitting rotational power to the rotatable cutting tool. The connection assembly is configured for engaging between the rotating motor device and the transmission assembly to thereby controllably rotate the cutting tool and remove tissue. In some embodiments, the apparatus includes a control unit for controlling operation of the apparatus, the control unit comprises an activation mechanism for activating the rotatable cutting tool, and a controller configured for operating the activation mechanism to generate a single fixed activation signal of a known intensity and duration during a predetermined time interval, thereby restricting operation of the cutting tool during the time interval to the single activation signal only.

The invention relates to an arrangement for delivering a medical implant into a hollow body organ (100) comprising a wire (10) and a compressible and expandable medical implant (11) which is tubular in shape, wherein the implant (11) in the compressed state is detachably connected to the wire (10) by at least one engagement element (12), wherein the engagement element (12) has a plurality of filaments (13) which extend outwards in the radial direction of the wire (10) and engage in the implant (11) during use.

Devices, systems for localized delivery of a chemotherapy, hormonal therapy or targeted drug / biologic therapy to a target tissue area of an internal body organ of a patient. A catheter 10 forms a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin. The drug may saturate the target tissue area and pass therethrough into the lymphatic system or interstitial space, which may serve as a reservoir of the drug for continued therapeutic treatment after withdrawal of the catheter. The chamber is evacuated at the end of the treatment session.

The utility model provides a device for controlling a flow state in a body organ, which comprises a shell, a flow sensor, a controller and a controller, the shell comprises an upper shell, a lower shell and a central shell, and the upper shell and the lower shell are mounted at two ends of the central shell; the rotating piece comprises a rotating shell and a rack part, and the rotating shell is installed between the upper shell and the lower shell; the rack part is mounted on the rotating shell; the driving part comprises a driving shell, a motor, a motor shaft and a gear, and the motor is installed on the driving shell; at least one lifting platform and at least one control piece, wherein the lifting platform is mounted on the inner side of the rotating shell; the control piece penetrates through the center shell and makes contact with the lifting table. The technical problem that when flow in the alimentary canal in the human body is out of control, serious harm is caused to the health of the human body is solved, the driving piece drives the rotating piece, the control piece extrudes or releases the alimentary canal, effective control over the flow in the alimentary canal is achieved, and the effect that the alimentary canal flows out of control is achieved. The technical effect of preventing the human body from suffering from digestive diseases is achieved.

The lead implanted in a body to apply electrical stimulation to body organs may include: an electrode wire having one end provided as an insertion portion to be inserted into a body and the other end provided as an interface portion for connection with an external device to transmit a stimulation signal: a plurality of first electrodes in the insertion portion; a plurality of second electrodes on the interface portion; and a plurality of signal lines interconnecting the first electrodes and the second electrodes, wherein the insertion portion of the electrode wire includes a plurality of support portions on which the first electrodes are respectively disposed and a plurality of stretchable portions between the support portions and expandable and contractible, and further includes an operation unit for pushing or pulling each support portion in a longitudinal direction of the electrode wire to adjust a position of the support portion.

The application relates to a whole-body organ metabolism network analysis method, device, equipment and storage medium. The method comprises the following steps: collecting a PET image of a subject, obtaining SUV images, Ki images and TAC data according to the PET image, and collecting physiological information, clinical pathology information and daily habit information of the subject; metabolism characteristics are extracted based on the PET images, SUV images and Ki images corresponding to the region of interest; the TAC data of each organ is curve-fitted by using the PET image, and the metabolism disturbance under different organs is represented by using the fitting residual error; a whole-body organ metabolism network is constructed according to the physiological information, clinical pathology information, daily habit information, metabolism characteristics and metabolism disturbance; and the whole-body organ metabolism of the subject is analyzed through the whole-body organ metabolism network. The application avoids individual differences, can more comprehensively capture the metabolism correlation among whole-body organs of a specific disease, and is helpful for early diagnosis, accurate evaluation and individualized treatment of clinical diseases.

An apparatus for use in tissue removal from a body organ is presented. The apparatus comprises a hand-held probe device, a rotating motor device and a connection assembly configured for removably interconnecting between the hand-held probe device and the rotating motor device. The hand-held probe device is disposable and comprises a housing having proximal and distal ends, a rotatable cutting tool extending distally from the distal end of the housing and being configured for cutting and removing tissue during rotation, and a transmission assembly passing inside the housing between the proximal and distal ends and being configured for transmitting rotational power to the rotatable cutting tool. The connection assembly is configured for engaging between the rotating motor device and the transmission assembly to thereby controllably rotate the cutting tool and remove tissue. In some embodiments, the apparatus includes a control unit for controlling operation of the apparatus, the control unit comprises an activation mechanism for activating the rotatable cutting tool, and a controller configured for operating the activation mechanism to generate a single fixed activation signal of a known intensity and duration during a predetermined time interval, thereby restricting operation of the cutting tool during the time interval to the single activation signal only.

The present invention relates to an artificial contractile device comprising at least one contractile element (1) comprising a flexible strip (4) extending in a longitudinal direction and a closure (6) for forming the contractile element (1) into a closed loop around a hollow body organ, the closure (6) being situated at a first extremity of the flexible strip (4). The contractile element is adapted to contract a hollow body organ, in such a way that said contractile element (1) may be in a resting position or in an activated position. The artificial contractile device further comprises a flexible transmission (3) comprising a tensioning element (31) being anchored at a first end (311) to a first anchoring point (A) on the flexible strip (4), said flexible transmission (3) being adapted to tighten the contractile element (1) formed in a closed loop around said hollow body organ upon application of a traction force at and end of the tensioning element (2031) by an actuator (7). The artificial contractile device also comprises a connector (5) adapted to connect the flexible transmission (3) to a said actuator (7), a second end (312) of said tensioning element (2031) being anchored in said connector (5).

Apparatuses and methods for facilitating the guided delivery of a drug into a patient's body organ are disclosed. An apparatus (2500) for facilitating the guided delivery of a drug into a patient's body organ can include a container (2504) configured to package a drug, a needle (2502) having a passage therethrough and a sharp distal tip, and a needle sheath (2506) at least partially surrounding a shaft of the needle. The needle sheath can include a distal surface, wherein the sharp distal tip of the needle can be configured to extend through an opening in the distal surface. The needle sheath can be movable relative to the needle along an axis of the needle to control a distance from the distal surface to the distal tip of the needle.

The present invention provides an improved vascular occlusion device having improved flexibility and retention of the type fabricated from braided tubular metal fabric having an expanded preset configuration and an elongated collapsed reduced diameter configuration for delivery through a catheter to a treatment site and shaped to create an occlusion of an abnormal opening in a body organ or vessel, the woven metal fabric having a memory property whereby the medical device tends to return to said expanded preset configuration when unconstrained. The device further including at least one disk portion adjacent a body cylindrical portion formed from the fabric and having a transition diameter between the disk and cylindrical portion, significantly smaller than the diameter of the disk and the diameter of the cylindrical portion.

A biopsy guide for guiding biopsy needles towards a body organ includes a clasp for attaching to an ultrasound probe. The biopsy guide includes in addition a guide tower extending upwards away from the clasp that in turn includes a plurality of parallel guide channels placed one above the other and defining each a needle passage that extends through the guide tower between rear and forward open ends. Each guide channel at least along a rear section thereof opens laterally sideways along a slit that has a width sized to be generally similar to or larger than a width of the needle passage.

Devices, systems, and methods for localized delivery of a chemotherapy, hormonal therapy, or targeted drug / biologic therapy to a target tissue area of an internal body organ of a patient. Computer systems may be used for planning and navigation in super selective drug delivery via a tracheobronchial airway. A catheter may be used to form a sealed treatment chamber in a natural lumen extending through the target tissue area. Air is purged from the chamber, which is then filled with a liquid drug solution for an adequate treatment session time, solution volume and drug concentration to saturate the target tissue area, thereby providing the treatment. The liquid drug solution may be circulated or recirculated through the chamber or maintained stationary therewithin to saturate the target tissue area. The chamber is evacuated at the end of the treatment session.

Devices, systems and methods for localized delivery of a fluid therapy to a target tissue area of an internal body organ of a patient. A catheter forms a sealed treatment chamber in a natural lumen extending through the target tissue area. A fluid solution fills the treatment chamber for an adequate treatment session time, solution volume and / or drug concentration thereby providing the treatment. The fluid solution may be circulated or recirculated through the chamber or maintained stationary therewithin to treat the organ.

A lead structure according to an embodiment of the present disclosure may include: includes a lead having an electrode wire having one end provided as an insertion portion to be inserted into a body and the other end provided as an interface portion for connection with an external device, a first electrode in the insertion portion to transmit electrical stimulation to body organs, a second electrode on the interface portion to receive electrical stimulation applied from outside, and a signal line configured to interconnect the first electrode and the second electrode and transmit the electrical stimulation received by the second electrode to the first electrode; and a lead case configured to surround the lead, and a conductive plate configured to apply electrical stimulation to body organs and a support plate configured to provide electrical stimulation from the first electrode to the conductive plate by contacting the first electrode.

Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently and synergistically for the prevention, treatment, and inhibition of excess cytokines caused by the immune response to extreme viral and bacterial infections, including the inhibition of COVID-19, Rhinovirus and / or other virus spike proteins and mRNA vaccine spike proteins from attaching to body organ cells, penetrating cell membranes, and the replication of virus particles and spike proteins inside the cells. Inhibition of inflammation and prevention of long-term side effects, health issues (long-haulers), and disease caused by the SARS-COV-2 and its variants, Rhinovirus, other viruses, bacteria, and mRNA vaccines are provided by the nutraceutical compositions. Specific combinations of these compounds work synergistically to increase the efficacy of the independent nutraceuticals in treatment.

The invention relates to an arrangement for feeding a radially compressible and expandable implant (10) into a hollow body organ, comprising a transport wire (11) having an engagement element (12), wherein the implant (10) is tubular and, in the compressed state, is detachably connected to the transport wire (11) by the engagement element (12), and wherein the implant (10), in the at least partially expanded state, can be released by a relative movement between the engagement element (12) and the implant (10) in a release direction, wherein the transport wire (11) has a positioning element (13) with a plurality of flexible windings extending in the radial direction of the transport wire (11), wherein an outer contour of the engagement element (12) in the released state of the implant (10) is smaller than a contour of the positioning element (13), such that the engagement element (12) can be positioned in the implant (10).

Combinations of cannabinoids, vitamins, trace elements, bioactive components, bioflavonoid polyphenols, proteolytic enzymes, amino acids, and antioxidants which work independently and synergistically for the prevention, treatment, and inhibition of excess cytokines caused by the immune response to extreme viral and bacterial infections, including the inhibition of COVID-19, Rhinovirus and / or other virus spike proteins and mRNA vaccine spike proteins from attaching to body organ cells, penetrating cell membranes, and the replication of virus particles and spike proteins inside the cells. Inhibition of inflammation and prevention of long-term side effects, health issues (long-haulers), and disease caused by the SARS-CoV-2 and its variants, Rhinovirus, other viruses, bacteria, and mRNA vaccines are provided by the nutraceutical compositions. Specific combinations of these compounds work synergistically to increase the efficacy of the independent nutraceuticals in treatment.

Among other things, there are disclosed embodiments of belts or bands that can be used in treatments for tricuspid valve regurgitation. In some embodiments, such belts may be heat-set in a particular configuration to effectively decrease tricuspid annulus when deployed around the atrioventricular groove. Embodiments include one or more tensioning sutures for applying cinching or tightening to belts when deployed, and structure for effectively distributing force during such tightening.

An apparatus for use in tissue removal from a body organ is presented. The apparatus comprises a hand-held probe device, a rotating motor device and a connection assembly configured for removably interconnecting between the hand-held probe device and the rotating motor device. The hand-held probe device is disposable and comprises a housing having proximal and distal ends, a rotatable cutting tool extending distally from the distal end of the housing and being configured for cutting and removing tissue during rotation, and a transmission assembly passing inside the housing between the proximal and distal ends and being configured for transmitting rotational power to the rotatable cutting tool. The connection assembly is configured for engaging between the rotating motor device and the transmission assembly to thereby controllably rotate the cutting tool and remove tissue. In some embodiments, the apparatus includes a control unit for controlling operation of the apparatus, the control unit comprises an activation mechanism for activating the rotatable cutting tool, and a controller configured for operating the activation mechanism to generate a single fixed activation signal of a known intensity and duration during a predetermined time interval, thereby restricting operation of the cutting tool during the time interval to the single activation signal only.

1. Arrangement for delivering a medical implant into a hollow body organ, comprising a wire (10) and a compressible and expandable medical implant (11) which is tubular in shape, - wherein the implant (11) in the compressed state is detachably connected to the wire (10) by at least one engagement element (12) for transmitting force in the axial direction, wherein the engagement element (12) has at least one projection (13) which extends radially outwards and engages the implant (11), and - wherein the implant (11) in the at least partially expanded state can be released by a relative movement between the engagement element (12) and the implant (11) in a release direction, characterized in that the engagement element (12) has at least one sliding surface (14) which is inclined and / or curved in the release direction and cooperates with the projection (13) to release the implant (11).